The AHA joined by the Association of American Medical Colleges and America’s Essential Hospitals today will urge a federal court to prevent the Department of Health and Human Services from reducing Medicare payments under the 340B drug savings program by nearly 30% effective Jan. 1. In a brief to be filed today in reply to the agency’s motion to dismiss their lawsuit challenging the reduction, the hospital groups say the payment cut “far exceeds” HHS’s authority to adjust the reimbursement rate and warrants a preliminary injunction to prevent “imminent” and “actual” harm to their members. Thirty-two state and regional hospital associations also today will urge the court in a friend-of-the-court brief to grant the preliminary injunction, arguing that the estimated $1.6 billion cut “will have devastating consequences for safety-net providers and the millions of patients they serve.”

Related News Articles

Headline
A U.S. district court judge for the District of Columbia May 15 ruled the Department of Health and Human Services must preapprove the use of 340B “rebate…
Headline
The Centers for Medicare & Medicaid Services May 12 released draft guidance for the third round of negotiations for the Medicare Drug Price Negotiation…
Headline
The AHA May 14 filed an amicus brief in the U.S. District Court for the District of South Dakota in defense of the state’s 340B contract pharmacy law…
Headline
The AHA May 9 urged the Department of Health and Human Services to deny drug companies’ requests to approve their unlawful 340B rebate models. “The 340B…
Headline
The White House May 12 released an executive order to reduce prescription drug costs by allowing consumers to make direct purchases from drug manufacturers at…
Headline
The AHA May 8 filed an amicus brief in the U.S. District Court for the District of Nebraska in defense of the state’s 340B contract pharmacy law prohibiting…